Amidst a struggling IPO market, Forbion drums up half a billion in private cash for second late-stage fund

Lei Lei Wu

News Reporter

European venture capital firm Forbion announced Thursday morning an initial close of €470 million ($504 million) for its second growth fund meant to boost late …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Amidst a struggling IPO market, Forbion drums up half a billion in private cash for second late-stage fund

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Amidst a strug­gling IPO mar­ket, For­bion drums up half a bil­lion in pri­vate cash for sec­ond late-stage fund

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Amidst a struggling IPO market, Forbion drums up half a billion in private cash for second late-stage fund